jcm-logo

Journal Browser

Journal Browser

Bronchoscopy and Interventional Pulmonology

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Respiratory Medicine".

Deadline for manuscript submissions: 20 June 2026 | Viewed by 1184

Special Issue Editors


E-Mail Website
Guest Editor
Pulmonary Department, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, USA
Interests: pulmonary disease; critical care medicine; interventional pulmonology; pleural disease; thoracic oncology

E-Mail Website
Guest Editor
Department of Pulmonary and Critical Care Medicine, Medical College of Wisconsin, 8701 W Watertown Plank, Milwaukee, WI 53226, USA
Interests: interventional pulmonology; critical care medicine; pulmonary disease

Special Issue Information

Dear Colleagues,

Interventional pulmonology is an exciting and evolving subspecialty within the field of pulmonary medicine. It encompasses minimally invasive diagnostic and therapeutic bronchoscopic and pleural procedures to diagnose and treat a myriad of respiratory conditions such as emphysema, asthma, interstitial lung disease, central airway obstructions, and lung cancers. Continued advancements in the field have allowed for improved safety, accuracy, and benefits from these various procedures.  

Advances in the field of interventional pulmonology continue to occur. Bronchoscopic lung volume reduction continues to evolve, with multiple new therapeutic modalities in various trial stages. The safety profile and diagnostic impact of transbronchial lung cryobiopsies continue to improve through the leverage of new biopsy tools and guiding imaging modalities. New advances in therapies for both malignant and non-malignant central airway obstructions offer hope for both symptom palliation and improvement in life expectancy. The improvements in real-time visualization and the intraprocedural marking of peripheral pulmonary lesions during bronchoscopic biopsies offer increased diagnostic accuracy, the potential to facilitate a lung sparing surgery, and the possibility of ablative therapy in just one procedure.  

This Special Issue focused on “Bronchoscopy and Interventional Pulmonology”, welcomes experts to present a balanced overview of these exciting new possibilities, discussing the potential and limitations of each. Requisites for performing these procedures are also reviewed.

Dr. Bryan S. Benn
Dr. Jonathan Kurman
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • navigation-guided bronchoscopy
  • Robotic-guided bronchoscopy
  • 3D imaging integration
  • lung nodule/peripheral pulmonary lesion marking
  • transbronchial lung cryobiopsy and interstitial lung disease
  • malignant and benign central airway obstruction and stenosis
  • airway stents
  • pleuroscopic procedures
  • bronchoscopic lung volume reduction

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

10 pages, 213 KB  
Article
Shape-Sensing Robotic-Assisted Bronchoscopy vs. Electromagnetic Robotic-Assisted Bronchoscopy—A Comparative Cohort Study
by See-Wei Low, Fatima Abdeljaleel, Brett Kemper, Yifan Wang, Xiaofeng Wang, Christopher Yurosko, Graham Stockdale, Colin Gillespie, Thomas Gildea, Sonali Sethi, Joseph Cicenia, Michael Machuzak, Francisco Almeida and Bryan S. Benn
J. Clin. Med. 2026, 15(3), 1284; https://doi.org/10.3390/jcm15031284 - 5 Feb 2026
Viewed by 698
Abstract
Introduction: Lung cancer is a leading cause of cancer-related deaths globally, with approximately 1.5 million new peripheral pulmonary lesions (PPLs) detected annually in the United States. Robotic-assisted bronchoscopy (RAB) has emerged as a promising technology, with two platforms initially approved, the Monarch [...] Read more.
Introduction: Lung cancer is a leading cause of cancer-related deaths globally, with approximately 1.5 million new peripheral pulmonary lesions (PPLs) detected annually in the United States. Robotic-assisted bronchoscopy (RAB) has emerged as a promising technology, with two platforms initially approved, the Monarch platform (Auris Health Inc, Redwood City, CA, USA) and the Ion Endoluminal System (Intuitive Surgical, Sunnyvale, CA, USA), offering improved stability and distal airway visualization. As RAB adoption increases, there is a critical need for comparative effectiveness data of these systems to guide clinical decision-making and institutional investments. This study aims to compare the diagnostic yield and safety profiles of the Ion and Monarch RAB platforms after introduction at a single institution. Methods: We conducted a retrospective chart review of patients undergoing RAB in the first six months following the introduction of each platform. Demographic and radiographic data were collected. Diagnostic yield was defined as obtaining a malignant or specific benign diagnosis from bronchoscopy. Results: The study included 56 Ion and 36 Monarch procedures. Diagnostic yield was similar between Ion (75%) and Monarch (72%) groups (p = 0.8), with an adjusted odds ratio 0.89 (95% CI 0.30–2.72). Complications were low, with one pneumothorax occurring in each group. Conclusions: Early adoption and use of both RAB platforms suggests comparable diagnostic yields and safety profiles in our limited sample size. Larger studies including standardized anesthesia protocol and systematic use of real-time imaging are needed for further evaluation and comparative analysis. Full article
(This article belongs to the Special Issue Bronchoscopy and Interventional Pulmonology)
Back to TopTop